Miacalcin and Xopenex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Miacalcin (calcitonin, salmon) and Xopenex (levalbuterol hydrochloride). Common drug interactions include alopecia among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Miacalcin and Xopenex. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Miacalcin?

Miacalcin has active ingredients of calcitonin, salmon. It is often used in osteoporosis. eHealthMe is studying from 5,437 Miacalcin users. Check the latest studies of Miacalcin.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.



On Jul, 10, 2026

26 people who take Miacalcin and Xopenex together, and have interactions are studied.

Miacalcin and Xopenex drug interactions.

What are the common drug interactions of Miacalcin and Xopenex, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Fatigue (feeling of tiredness)
  3. Oral candidiasis (fungal infection of mouth)
  4. Pain
  5. Pyrexia (fever)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Headache (pain in head)
  8. Chest pain
  9. Dizziness
  10. Myalgia (muscle pain)

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Dry mouth
  3. Gingival atrophy (wasting of part of gums)
  4. Large intestine perforation (hole in large intestine)
  5. Tolerance increased
  6. Tooth disorder (tooth disease)
  7. Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Miacalcin and Xopenex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Pituitary-dependent cushing's syndrome (pituitary dependent hypercortisolism)
  3. Rib fracture

50-59:

  1. Hypoxia (low oxygen in tissues)
  2. Intertrigo candida (infection of the skin by candida albicans)
  3. Irritable bowel syndrome
  4. Kyphoscoliosis (abnormal curving of the spine)
  5. Libido decreased (loss of interest in sex)
  6. Lipoma (a growth of fatty tissue that slowly develops just under your skin)
  7. Lymphadenopathy (disease or enlargement of lymph nodes)
  8. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  9. Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
  10. Migraine (headache)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Oedema peripheral (superficial swelling)
  3. Bile duct stone
  4. Carcinoembryonic antigen increased
  5. Colonic polyp (extra part of colon tissue grow in intestine)
  6. Cough
  7. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  8. Fatigue (feeling of tiredness)
  9. Haemoglobin decreased
  10. Irritability

What are the existing conditions these people have? *

  1. Hypersensitivity: 4 people, 15.38%
  2. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 3 people, 11.54%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 11.54%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 11.54%
  5. Pain: 3 people, 11.54%
  6. Chronic Obstructive Airways Disease: 3 people, 11.54%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 11.54%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
  9. Cough: 3 people, 11.54%
  10. Depression: 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Miacalcin and Xopenex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Miacalcin and Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Miacalcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Miacalcin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcitonin, salmon and levalbuterol hydrochloride (the active ingredients of Miacalcin and Xopenex, respectively), and Miacalcin and Xopenex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: